APA

Gowda N., Dandu A., Singh J., Biswas S., Raghav V., Lakshmi M. N., Shilpa P. C., Sunil V., Reddy A., Sadasivuni M., Aparna K., Verma M. K., Moolemath Y., Anup M. O., Venkataranganna M. V., Somesh B. P. & Jagannath M. R. (20150511). Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats. : BMC pharmacology & toxicology.

Chicago

Gowda Nagesh, Dandu Anilkumar, Singh Jaideep, Biswas Sanghamitra, Raghav Vijaya, Lakshmi Mudigere N, Shilpa Pavagada C, Sunil Venkategowda, Reddy Ashokkumar, Sadasivuni Manojkumar, Aparna Kumaraswamy, Verma Mahesh Kumar, Moolemath Yoganand, Anup Mammen O, Venkataranganna Marikunte V, Somesh Baggavalli P and Jagannath Madanahalli R. 20150511. Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats. : BMC pharmacology & toxicology.

Harvard

Gowda N., Dandu A., Singh J., Biswas S., Raghav V., Lakshmi M. N., Shilpa P. C., Sunil V., Reddy A., Sadasivuni M., Aparna K., Verma M. K., Moolemath Y., Anup M. O., Venkataranganna M. V., Somesh B. P. and Jagannath M. R. (20150511). Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats. : BMC pharmacology & toxicology.

MLA

Gowda Nagesh, Dandu Anilkumar, Singh Jaideep, Biswas Sanghamitra, Raghav Vijaya, Lakshmi Mudigere N, Shilpa Pavagada C, Sunil Venkategowda, Reddy Ashokkumar, Sadasivuni Manojkumar, Aparna Kumaraswamy, Verma Mahesh Kumar, Moolemath Yoganand, Anup Mammen O, Venkataranganna Marikunte V, Somesh Baggavalli P and Jagannath Madanahalli R. Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats. : BMC pharmacology & toxicology. 20150511.